Given the acknowledged limitation of CD34 in terms of specificity, it is prudent to adopt a comprehensive approach that incorporates the assessment of CD34 alongside CD31, ERG, F8, and additional pertinent markers for an accurate diagnosis of epithelioid hemangioendothelioma (EHE). This evidence concerns the gene CD34 and epithelioid hemangioendothelioma.